Batch 001 - Live Allocation
Next Release: Aug 2026
Demo · Switch Role
Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -

Testing & Certificates

Every lot we've tested

One page, every released batch - purity, endotoxin, and heavy metals, from Janoshik Analytical. Nothing here is hand-kept: it's generated from the same certificate data shown on each product page, so the two can never disagree.

Lots published
7
Compounds
7
Endotoxin tested
3
Heavy metals tested
1
Lab
Janoshik Analytical
Lead Visual · Pharmacopoeial Reference
Endotoxin Tolerance & Safety Headroom
ENDOTOXIN · MEASURED vs PERMITTEDEvery lot against the moving pharmacopoeial limit (USP <85>)0.010.11101001,00010,000EU/mgRetatrutidetypical 1–12 mg82–985× underLIMIT0.3554MOTS-ctypical 2.5–5 mg189–378× underLIMIT0.3706GHRH Stacktypical 0.25 mg562× underLIMIT2.4910Measured result (this lot)Permitted ceiling across dose rangeSafety Headroom
Independently tested by Janoshik Analytical, LAL method. Results are specific to the lot tested. Limits follow USP <85> for parenteral products and assume a 70 kg adult.

Tested Compounds - Delivered Endotoxin vs USP <85> Limit

Publishing results with dose ladders rather than raw concentration alone - a higher EU/mg figure in a micro-dosed compound can still deliver less endotoxin per injection than a lower figure dosed higher up its range.

CompoundMeasured (LAL)Typical Dose RangeDelivered Per DosePermitted CeilingSafety Headroom
Retatrutide (Retatrutide-2026-07-30)0.3554 EU/mgtypical 1–12 mg0.36–4.26 EU350 EU82–985× under
MOTS-c (MOTS-C-2026-07-30)0.3706 EU/mgtypical 2.5–5 mg0.93–1.85 EU350 EU189–378× under
GHRH Stack (GHRH-Stack-2026-07-30)2.491 EU/mgtypical 0.25 mg0.623 EU350 EU562× under

* Independently tested by Janoshik Analytical (LAL method). Results are specific to the lot tested. Limits follow USP <85> for parenteral products, 70 kg adult.

Official Database
Batch Certificates of Analysis
CompoundLotLabeledActualPurityEndotoxinHeavy metalsTestedReports
KPV-2026-07-305 mg5.07 mg98.471%not testednot testedJul 30, 2026
PURITY →Code 89URJP6SW7I4
Retatrutide-2026-07-305 mg5.16 mg99.726%As, Cd, Pb, Hg - not detectedJul 30, 2026
MOTS-C-2026-07-3010 mg9.56 mg98.643%not testedJul 30, 2026
PURITY →ENDOTOXIN →Code R2GZV78VN74L
Tesamorelin-2026-07-305 mg4.73 mg97.423%not testednot testedJul 30, 2026
PURITY →Code 9PCF8V7IKJBR
SS-31-2026-07-3010 mg7.68 mg?99.759%not testednot testedJul 30, 2026
PURITY →Code DUJPS4ZVCR3Y
GLOW-2026-07-3070 mg totalnot testednot testedJul 30, 2026
PURITY →Code 5N1JPJLXZFAC
GHRH-Stack-2026-07-3010 mg totalnot testedJul 30, 2026
PURITY →ENDOTOXIN →Code M6EBZBGH1M92
Regulatory Mechanism
Why the limit moves with dose

The regulatory limit is set on what enters the body, not on concentration - 5 EU per kilogram of body weight per hour, about 350 EU for a 70 kg adult. So the permitted EU/mg falls as the dose rises: the same per-mg figure can be comfortably within limit for a micro-dosed peptide and far outside it at 20 mg. EU/mg cannot be compared between compounds - a product with a higher EU/mg may deliver less endotoxin per injection than one with a lower figure.

Dose bandExampleTypical dosePermitted EU/mg
Micro-doseCJC-1295 / Ipamorelin0.25 mg1,400 EU/mg
Low doseMOTS-c, Retatrutide (early titration)2.5 mg140 EU/mg
Moderate doseRetatrutide (maintenance)10 mg35 EU/mg
High doseBPC-157, amino blends20 mg17.5 EU/mg
Every certificate above is issued by Janoshik Analytical, an independent third-party lab. Reports carrying a verify code can be checked directly against the lab's own records.
janoshik.com/verification →

Results shown are specific to the lot tested and do not carry forward to future batches. Endotoxin limits follow USP <85> / pharmacopoeial guidance for parenteral products and assume a 70 kg adult. This page is educational information, not medical advice - your physician determines what is appropriate for you.

VL
Vivre Labs
Institutional Longevity

Clinical optimization through institutional medicine. All protocols verified and lot-tested, MSO-administered, hospital-integrated.

V-Series

Peptides

Metabolic
Repair & Aesthetic
Neurological
Growth & Hormonal
Longevity & Immune
Sexual Health

Navigate

Verification

DEMO SITE - PRESENTATION PURPOSES ONLY. All protocols verified and lot-tested, dispensed after comprehensive medical evaluation. Compounds sourced from registered cGMP compounding pharmacies. Individual results vary. MSO structures and revenue models are illustrative for partner conversations. Regulatory outcomes reference publicly disclosed FDA processes and are anticipated but not guaranteed.

© 2026 Vivre Labs. All rights reserved.

cGMPLot-TestedDemo

Demonstration prototype - not a live service